Zinc metalloproteinases and amyloid beta-peptide metabolism: The positive side of proteolysis in Alzheimer's disease

Biochemistry Research International

Volumn , Issue , 2011, Pages

  Parkin, Edward ^a   Gough, Mallory ^a   Parr Sturgess, Catherine ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78349293078     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2011/721463     Document Type: Review

References (143)

1. Schorer C. E., Historical essay: Kraepelin's description of Alzheimer's disease International Journal of Aging amp; Human Development 1985 21 3 235 238
2. Duyckaerts C., Delatour B., Potier M.-C., Classification and basic pathology of Alzheimer disease Acta Neuropathologica 2009 118 1 5 36
3. Medeiros R., Baglietto-Vargas D., Laferla F. M., The role of tau in Alzheimer's disease and related disorders. CNS Neuroscience Therapeutics. In press
4. de Strooper B., Proteases and proteolysis in alzheimer disease: a multifactorial view on the disease process Physiological Reviews 2010 90 2 465 494
5. Pimplikar S. W., Reassessing the amyloid cascade hypothesis of Alzheimer's disease International Journal of Biochemistry and Cell Biology 2009 41 6 1261 1268
6. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., Krafft G. A., Klein W. L., Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6448 6453
7. Walsh D. M., Hartley D. M., Kusumoto Y., Fezoui Y., Condron M. M., Lomakin A., Benedek G. B., Selkoe D. J., Teplow D. B., Amyloid -protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates Journal of Biological Chemistry 1999 274 36 25945 25952
8. Selkoe D. J., Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 2001 81 2 741 766
9. Mattson M. P., Cellular actions of -amyloid precursor protein and its soluble and fibrillogenic derivatives Physiological Reviews 1997 77 4 1081 1132
10. Hooper N. M., Trew A. J., Parkin E. T., Turner A. J., The role of proteolysis in Alzheimer's disease Advances in Experimental Medicine and Biology 2000 477 379 390
11. Haass C., Take fiveBACE and the -secretase quartet conduct Alzheimer's amyloid -peptide generation EMBO Journal 2004 23 3 483 488
12. Allinson T. M. J., Parkin E. T., Turner A. J., Hooper N. M., ADAMs family members as amyloid precursor protein -secretases Journal of Neuroscience Research 2003 74 3 342 352
13. Wang R., Meschia J. F., Cotter R. J., Sisodia S. S., Secretion of the /A4 amyloid precursor protein: identification of a cleavage site in cultured mammalian cells Journal of Biological Chemistry 1991 266 25 16960 16964
14. Skovronsky D. M., Moore D. B., Milla M. E., Doms R. W., Lee V. M.-Y., Protein kinase C-dependent -secretase competes with -secretase for cleavage of amyloid- precursor protein in the trans-Golgi network Journal of Biological Chemistry 2000 275 4 2568 2575
15. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojiro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., Van Leuven F., Fahrenholz F., A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model Journal of Clinical Investigation 2004 113 4 1456 1464
16. Caill I., Allinquant B., Dupont E., Bouillot C., Langer A., Mller U., Prochiantz A., Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone Development 2004 131 9 2173 2181
17. Pietrzik C. U., Hoffmann J., Stber K., Chen C.-Y., Bauer C., Otero D. A. C., Roch J.-M., Herzog V., From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 4 1770 1775
18. Saitoh T., Sundsmo M., Roch J.-M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D. B., Secreted form of amyloid protein precursor is involved in the growth regulation of fibroblasts Cell 1989 58 4 615 622 (Pubitemid 19210955)
19. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., Masters C. L., The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth Neuron 1992 9 1 129 137
20. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., Mattson M. P., Increased activity-regulating and neuroprotective efficacy of -secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain Journal of Neurochemistry 1996 67 5 1882 1896
21. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Rydel R. E., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the -amyloid precursor protein Neuron 1993 10 2 243 254
22. Morimoto T., Novel domain-specific actions of amyloid precursor protein on developing synapses Journal of Neuroscience 1998 18 22 9386 9393
23. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E., Mattson M. P., Secreted forms of -amyloid precursor protein protect against ischemic brain injury Journal of Neurochemistry 1994 63 2 781 784
24. Thornton E., Vink R., Blumbergs P. C., van den Heuvel C., Soluble amyloid precursor protein reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats Brain Research 2006 1094 1 38 46
25. Meziane H., Dodart J.-C., Mathis C., Little S., Clemens J., Paul S. M., Ungerer A., Memory-enhancing effects of secreted forms of the -amyloid precursor protein in normal and amnestic mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 21 12683 12688
26. Ring S., Weyer S., Kilian S. W., The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice Journal of Neuroscience 2007 27 7817 7826
27. Roberts S. B., Ripellino J. A., Ingalls K. M., Robakis N. K., Felsenstein K. M., Non-amyloidogenic cleavage of the -amyloid precursor protein by an integral membrane metalloendopeptidase Journal of Biological Chemistry 1994 269 4 3111 3116
28. Sisodia S. S., -Amyloid precursor protein cleavage by a membrane-bound protease Proceedings of the National Academy of Sciences of the United States of America 1992 89 13 6075 6079
29. Arribas J., Coodly L., Vollmer P., Kishimoto T. K., Rose-John S., Massagu J., Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors Journal of Biological Chemistry 1996 271 19 11376 11382
30. Parvathy S., Hussain I., Karran E. H., Turner A. J., Hooper N. M., Alzheimer's amyloid precursor protein -secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase Biochemistry 1998 37 6 1680 1685 (Pubitemid 28093684)
31. Racchi M., Solano D. C., Sironi M., Govoni S., Activity of -secretase as the common final effector of protein kinase C-dependent and -independent modulation of amyloid precursor protein metabolism Journal of Neurochemistry 1999 72 6 2464 2470
32. Parkin E. T., Watt N. T., Turner A. J., Hooper N. M., Dual Mechanisms for Shedding of the Cellular Prion Protein Journal of Biological Chemistry 2004 279 12 11170 11178
33. Taylor D. R., Parkin E. T., Cocklin S. L., Ault J. R., Aschcroft A. E., Turner A. J., Hooper N. M., Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein Journal of Biological Chemistry 2009 284 34 22590 22600
34. Reiss K., Saftig P., The "A Disintegrin And Metalloprotease" (ADAM) family of sheddases: physiological and cellular functions Seminars in Cell and Developmental Biology 2009 20 2 126 137
35. Anders A., Gilbert S., Garten W., Postina R., Fahrenholz F., Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases The FASEB Journal 2001 15 10 1837 1839
36. Loechel F., Wewer U. M., Activation of ADAM 12 protease by copper FEBS Letters 2001 506 1 65 68
37. Hwang E. M., Kim S.-K., Sohn J.-H., Lee J. Y., Kim Y., Kim Y. S., Mook-Jung I., Furin is an endogenous regulator of -secretase associated APP processing Biochemical and Biophysical Research Communications 2006 349 2 654 659
38. Lopez-Perez E., Zhang Y., Frank S. J., Creemers J., Seidah N., Checler F., Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10 Journal of Neurochemistry 2001 76 1532 1539
39. Milla M. E., Gonzales P. E., Leonard J. D., The TACE zymogen: re-examining the role of the cysteine switch Cell Biochemistry and Biophysics 2006 44 3 342 348
40. Cal S., Freije J. M. P., Lpez J. M., Takada Y., Lpez-Otn C., ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the v 3 integrin through an RGD-independent mechanism Molecular Biology of the Cell 2000 11 4 1457 1469
41. Gaultier A., Cousin H., Darribre T., Alfandari D., ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin Journal of Biological Chemistry 2002 277 26 23336 23344
42. Thodeti C. K., Frhlich C., Nielsen C. K., Takada Y., Fssler R., Albrechtsen R., Wewer U. M., ADAM12-mediated focal adhesion formation is differently regulated by 1 and 3 integrins FEBS Letters 2005 579 25 5589 5595
43. Zhao Z., Gruszczynska-Biegala J., Cheuvront T., Yi H., Von Der Mark H., Von Der Mark K., Kaufman S. J., Zolkiewska A., Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin 7 1 Experimental Cell Research 2004 298 1 28 37
44. Zigrino P., Steiger J., Fox J. W., Lffek S., Schild A., Nischt R., Mauch C., Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration Journal of Biological Chemistry 2007 282 42 30785 30793
45. Zolkiewska A., Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain Experimental Cell Research 1999 252 2 423 431
46. White J., Bridges L., DeSimone D., Tomczuk M., Wolfsberf T., Introduction to the ADAM Family 2005 4 Dordrecht, The Netherlands Springer
47. Chantry A., Gregson N. A., Glynn P., A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization Journal of Biological Chemistry 1989 264 36 21603 21607
48. Chantry A., Gregson N., Glynn P., Degradation of myelin basic protein by a membrane-associated metalloprotease: neural distribution of the enzyme Neurochemical Research 1992 17 9 861 868
49. Moss M. L., Bomar M., Liu Q., Sage H., Dempsey P., Lenhart P. M., Gillispie P. A., Stoeck A., Wildeboer D., Bartsch J. W., Palmisano R., Zhou P., The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events Journal of Biological Chemistry 2007 282 49 35712 35721
50. Escrevente C., Morais V. A., Keller S., Soares C. M., Altevogt P., Costa J., Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme Biochimica et Biophysica Acta 2008 1780 6 905 913
51. Yamazaki K., Mizui Y., Sagane K., Tanaka I., Assignment of a disintegrin and metalloproteinase domain 10 (Adam10) gene to mouse chromosome 9 Genomics 1997 46 3 528 529
52. Yamazaki K., Mizui Y., Tanaka I., Radiation hybrid mapping of human ADAM10 gene to chromosome 15 Genomics 1997 45 2 457 459
53. Prinzen C., Mller U., Endres K., Fahrenholz F., Postina R., Genomic structure and functional characterization of the human ADAM10 promoter FASEB Journal 2005 19 11 1522 1524
54. Tippmann F., Hundt J., Schneider A., Endres K., Fahrenholz F., Up-regulation of the -secretase ADAM10 by retinoic acid receptors and acitretin FASEB Journal 2009 23 6 1643 1654
55. Donmez G., Wang D., Cohen D. E., Guarente L., SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10 Cell 2010 142 320 332
56. Huovila A.-P. J., Turner A. J., Pelto-Huikko M., Krkkinen I., Ortiz R. M., Shedding light on ADAM metalloproteinases Trends in Biochemical Sciences 2005 30 7 413 422
57. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F., Constitutive and regulated -secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Proceedings of the National Academy of Sciences of the United States of America 1999 96 7 3922 3927
58. Hendriks L., Van Duijn C. M., Cras P., Cruts M., Van Hul W., Van Harskamp F., Warren A., McInnis M. G., Antonarakis S. E., Martin J.-J., Hofman A., Van Broeckhoven C., Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the -amyloid precursor protein gene Nature Genetics 1992 1 3 218 221
59. Amour A., Knight C. G., Webster A., Slocombe P. M., Stephens P. E., Knuper V., Docherty A. J. P., Murphy G., The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3 FEBS Letters 2000 473 3 275 279
60. Hartmann D., De Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lbke T., Illert A. L., Von Figura K., Saftig P., The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for -secretase activity in fibroblasts Human Molecular Genetics 2002 11 21 2615 2624
61. Obregon D. F., Rezai-Zadeh K., Bai Y., Sun N., Hou H., Ehrhart J., Zeng J., Mori T., Arendash G. W., Shytle D., Town T., Tan J., ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate- induced -secretase cleavage of amyloid precursor protein Journal of Biological Chemistry 2006 281 24 16419 16427
62. Zimmermann M., Gardoni F., Marcello E., Colciaghi F., Borroni B., Padovani A., Cattabeni F., Di Luca M., Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines Journal of Neurochemistry 2004 90 6 1489 1499
63. Marcello E., Gardoni F., Mauceri D., Romorini S., Jeromin A., Epis R., Borroni B., Cattabeni F., Sala C., Padovani A., Di Luca M., Synapse-associated protein-97 mediates -secretase ADAM10 trafficking and promotes its activity Journal of Neuroscience 2007 27 7 1682 1691
64. Marcello E., Gardoni F., Di Luca M., Prez-Otan I., An arginine stretch limits ADAM10 exit from the endoplasmic reticulum Journal of Biological Chemistry 2010 285 14 10376 10384
65. Black R. A., Rauch C. T., Kozlosky C. J., Peschon J. J., Slack J. L., Wolfson M. F., Castner B. J., Stocking K. L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K. A., Gerhart M., Davis R., Fitzner J. N., Johnson R. S., Paxton R. J., March C. J., Cerretti D. P., A metalloproteinase disintegrin that releases tumour-necrosis factor- from cells Nature 1997 385 6618 729 733
66. Moss M. L., Jin S.-L. C., Milla M. E., Bickett D. M., Burkhart W., Carter H. L., Chen W.-J., Clay W. C., Didsbury J. R., Hassler D., Hoffman C. R., Kost T. A., Lambert M. H., Leesnitzer M. A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L. K., Schoenen F., Seaton T., Su J.-L., Warner J., Willard D., Becherer J. D., Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor- Nature 1997 385 733 736
67. Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G. P., Bartunik H., Ellestad G. A., Reddy P., Wolfson M. F., Rauch C. T., Castner B. J., Davis R., Clarke H. R. G., Petersen M., Fitzner J. N., Cerretti D. P., March C. J., Paxton R. J., Black R. A., Bode W., Crystal structure of the catalytic domain of human tumor necrosis factor- -converting enzyme Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3408 3412
68. Pruessmeyer J., Ludwig A., The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer Seminars in Cell and Developmental Biology 2009 20 2 164 174
69. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., Greengard P., Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer /A4 amyloid protein precursor Proceedings of the National Academy of Sciences of the United States of America 1992 89 21 10075 10078
70. Merlos-Surez A., Fernndez-Larrea J., Reddy P., Baselga J., Arribas J., Pro-tumor necrosis factor- processing activity is tightly controlled by a component that does not affect Notch processing Journal of Biological Chemistry 1998 273 38 24955 24962
71. Blacker M., Noe M. C., Carty T. J., Goodyer C. G., LeBlanc A. C., Effect of tumor necrosis factor- converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons Journal of Neurochemistry 2002 83 6 1349 1357
72. Kuhn P. H., Wang H., Dislich B., ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons EMBO Journal 2010 29 17 3020 3032
73. Slack B. E., Ma L. K., Seah C. C., Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor- converting enzyme Biochemical Journal 2001 357 3 787 794
74. Hiraoka Y., Ohno M., Yoshida K., Okawa K., Tomimoto H., Kita T., Nishi E., Enhancement of -secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin Journal of Neurochemistry 2007 102 5 1595 1605
75. Asai M., Hattori C., Szab B., Sasagawa N., Maruyama K., Tanuma S.-I., Ishiura S., Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase Biochemical and Biophysical Research Communications 2003 301 1 231 235
76. Buxbaum J. D., Liu K.-N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P., Black R. A., Evidence that tumor necrosis factor converting enzyme is involved in regulated -secretase cleavage of the Alzheimer amyloid protein precursor Journal of Biological Chemistry 1998 273 43 27765 27767
77. Mohan M. J., Seaton T., Mitchell J., Howe A., Blackburn K., Burkhart W., Moyer M., Patel I., Waitt G. M., Becherer J. D., Moss M. L., Milla M. E., The tumor necrosis factor- converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity Biochemistry 2002 41 30 9462 9469
78. Weskamp G., Krtzschmar J., Reid M. S., Blobel C. P., MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains Journal of Cell Biology 1996 132 4 717 726 (Pubitemid 26069249)
79. Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S., Membrane-anchored metalloprotease MDC9 has an -secretase activity responsible for processing the amyloid precursor protein Biochemical Journal 1999 343, part 2 371 375
80. Roghani M., Becherer J. D., Moss M. L., Atherton R. E., Erdjument-Bromage H., Arribas J., Blackburn R. K., Weskamp G., Tempst P., Blobel C. P., Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity Journal of Biological Chemistry 1999 274 6 3531 3540
81. Hotoda N., Koike H., Sasagawa N., Ishiura S., A secreted form of human ADAM9 has an -secretase activity for APP Biochemical and Biophysical Research Communications 2002 293 2 800 805
82. Cong L., Jia J., Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiology of Aging. In press
83. Ciss M. A., Sunyach C., Lefranc-Jullien S., Postina R., Vincent B., Checler F., The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity Journal of Biological Chemistry 2005 280 49 40624 40631
84. Harris B., Pereira I., Parkin E., Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein Brain Research 2009 1296 203 215
85. Tousseyn T., Thathiah A., Jorissen E., Raemaekers T., Konietzko U., Reiss K., Maes E., Snellinx A., Serneels L., Nyabi O., Annaert W., Saftig P., Hartmann D., de Strooper B., ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the -secretase Journal of Biological Chemistry 2009 284 17 11738 11747
86. Zou J., Zhu F., Liu J., Wang W., Zhang R., Garlisi C. G., Liu Y.-H., Wang S., Shah H., Wan Y., Umland S. P., Catalytic activity of human ADAM33 Journal of Biological Chemistry 2004 279 11 9818 9830
87. Naus S., Reipschlger S., Wildeboer D., Lichtenthaler S. F., Mitterreiter S., Guan Z., Moss M. L., Bartsch J. W., Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8 Biological Chemistry 2006 387 3 337 346
88. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., Ishiura S., ADAM19 is tightly associated with constitutive Alzheimer's disease APP -secretase in A172 cells Biochemical and Biophysical Research Communications 2007 352 1 111 117
89. Hooper N. M., Families of zinc metalloproteases FEBS Letters 1994 354 1 1 6
90. Ohno M., Hiraoka Y., Matsuoka T., Tomimoto H., Takao K., Miyakawa T., Oshima N., Kiyonari H., Kimura T., Kita T., Nishi E., Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system Nature Neuroscience 2009 12 12 1506 1513
91. Malito E., Hulse R. E., Tang W.-J., Amyloid -degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin Cellular and Molecular Life Sciences 2008 65 16 2574 2585
92. Fernndez-Gamba A., Leal M. C., Morelli L., Castao E. M., Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease Current Pharmaceutical Design 2009 15 31 3644 3655
93. Vekrellis K., Ye Z., Qiu W. Q., Walsh D., Hartley D., Chesneau V., Rosner M. R., Selkoe D. J., Neurons regulate extracellular levels of amyloid -protein via proteolysis by insulin-degrading enzyme Journal of Neuroscience 2000 20 5 1657 1665
94. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E. A., Frosch M. P., Eckman C. B., Tanzi R. E., Selkoe D. J., Gunette S., Insulin-degrading enzyme regulates the levels of insulin, amyloid -protein, and the -amyloid precursor protein intracellular domain in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4162 4167
95. Farris W., Mansourian S., Leissring M. A., Eckman E. A., Bertram L., Eckman C. B., Tanzi R. E., Selkoe D. J., Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid -Protein American Journal of Pathology 2004 164 4 1425 1434
96. Leissring M. A., Farris W., Chang A. Y., Walsh D. M., Wu X., Sun X., Frosch M. P., Selkoe D. J., Enhanced proteolysis of -amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 2003 40 6 1087 1093
97. Miller B. C., Eckman E. A., Sambamurti K., Dobbs N., Martin Chow K., Eckman C. B., Hersh L. B., Thiele D. L., Amyloid- peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6221 6226
98. Venugopal C., Pappolla M. A., Sambamurti K., Insulysin cleaves the APP cytoplasmic fragment at multiple sites Neurochemical Research 2007 32 12 2225 2234
99. Bernstein H.-G., Ansorge S., Riederer P., Reiser M., Frlich L., Bogerts B., Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques Neuroscience Letters 1999 263 2-3 161 164
100. Morelli L., Llovera R. E., Mathov I., Lue L.-F., Frangione B., Ghiso J., Castao E. M., Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid vasculotropic variants and reduced activity in cerebral amyloid angiopathy Journal of Biological Chemistry 2004 279 53 56004 56013
101. Zhao Z., Xiang Z., Haroutunian V., Buxbaum J. D., Stetka B., Pasinetti G. M., Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease Neurobiology of Aging 2007 28 6 824 830
102. Prince J. A., Feuk L., Gu H. F., Johansson B., Gatz M., Blennow K., Brookes A. J., Genetic variation in a haplotype block spanning IDE influences Alzheimer disease Human Mutation 2003 22 5 363 371
103. Kim M., Hersh L. B., Leissring M. A., Ingelsson M., Matsui T., Farris W., Lu A., Hyman B. T., Selkoe D. J., Bertram L., Tanzi R. E., Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families Journal of Biological Chemistry 2007 282 11 7825 7832
104. Roques B. P., Noble F., Dauge V., Fournie-Zaluski M.-C., Beaumont A., Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology Pharmacological Reviews 1993 45 1 87 146
105. Howell S., Nalbantoglu J., Crine P., Neutral endopeptidase can hydrolyze -amyloid(1-40) but shows no effect on -amyloid precursor protein metabolism Peptides 1995 16 4 647 652
106. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H. -J., Hama E., Sekine-Aizawa Y., Saido T. C., Identification of the major A 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nature Medicine 2000 6 2 143 150
107. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N. P., Gerard C., Hama E., Lee H. -J., Saido T. C., Metabolic regulation of brain A by neprilysin Science 2001 292 5521 1550 1552
108. Huang S.-M., Mouri A., Kokubo H., Nakajima R., Suemoto T., Higuchi M., Staufenbiel M., Noda Y., Yamaguchi H., Nabeshima T., Saido T. C., Iwata N., Neprilysin-sensitive synapse-associated amyloid- peptide oligomers impair neuronal plasticity and cognitive function Journal of Biological Chemistry 2006 281 26 17941 17951
109. Akiyama H., Kondo H., Ikeda K., Kato M., McGeer P. L., Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid -protein (A ) deposition Brain Research 2001 902 2 277 281
110. Yasojima K., Akiyama H., McGeer E. G., McGeer P. L., Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of -amyloid peptide Neuroscience Letters 2001 297 2 97 100
111. Hellstrm-Lindahl E., Ravid R., Nordberg A., Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A levels Neurobiology of Aging 2008 29 2 210 221
112. Helisalmi S., Hiltunen M., Vepslinen S., Iivonen S., Mannermaa A., Lehtovirta M., Koivisito A. M., Alafuzoff I., Soininen H., Polymorphism in neprilysin gene affect the risk of Alzheimer's diasease in Finnish patients Journal of Neurology, Neurosurgery and Psychiatry 2004 75 12 1746 1748
113. Sakai A., Ujike H., Nakata K., Takehisa Y., Imamura T., Uchida N., Kanzaki A., Yamamoto M., Fujisawa Y., Okumura K., Kuroda S., Association of the neprilysin gene with susceptibility to late-onset Alzheimer's disease Dementia and Geriatric Cognitive Disorders 2004 17 3 164 169 (Pubitemid 38339742)
114. Miners J. S., Van Helmond Z., Chalmers K., Wilcock G., Love S., Kehoe P. G., Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy Journal of Neuropathology and Experimental Neurology 2006 65 10 1012 1021
115. Khimji A. -K., Rockey D. C., Endothelin-Biology and disease Cellular Signalling 2010 22 11 1615 1625
116. Schmidt M., Molecular characterization of human and bovine endothelin converting enzyme (ECE-1) FEBS Letters 1994 356 2-3 238 243
117. Valdenaire O., Rohrbacher E., Mattei M.-G., Organization of the gene encoding the human endothelin-converting enzyme (ECE-1) Journal of Biological Chemistry 1995 270 50 29794 29798
118. Eckman E. A., Reed D. K., Eckman C. B., Degradation of the Alzheimer's amyloid peptide by endothelin-converting enzyme Journal of Biological Chemistry 2001 276 27 24540 24548
119. Eckman E. A., Watson M., Marlow L., Sambamurti K., Eckman C. B., Alzheimer's disease -amyloid peptide is increased in mice deficient in endothelin-converting enzyme Journal of Biological Chemistry 2003 278 4 2081 2084
120. Eckman E. A., Adams S. K., Troendle F. J., Stodola B. A., Kahn M. A., Fauq A. H., Xiao H. D., Bernstein K. E., Eckman C. B., Regulation of steady-state -amyloid levels in the brain by neprilysin and endothelin- converting enzyme but not angiotensin-converting enzyme Journal of Biological Chemistry 2006 281 41 30471 30478
121. Jin Z., Luxiang C., Huadong Z., Yanjiang W., Zhiqiang X., Hongyuan C., Lihua H., Xu Y., Endothelin-converting enzyme-1 promoter polymorphisms and susceptibility to sporadic late-onset Alzheimer's disease in a Chinese population Disease Markers 2009 27 5 211 215
122. Palmer J. C., Baig S., Kehoe P. G., Love S., Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by A American Journal of Pathology 2009 175 1 262 270
123. Funalot B., Ouimet T., Claperon A., Fallet C., Delacourte A., Epelbaum J., Subkowski T., Lonard N., Codron V., David J. -P., Amouyel P., Schwartz J. -C., Helbecque N., Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease Molecular Psychiatry 2004 9 12 1122 1128 (Pubitemid 40065457)
124. Weeraratna A. T., Kalehua A., DeLeon I., Bertak D., Maher G., Wade M. S., Lustig A., Becker K. G., Wood W. III, Walker D. G., Beach T. G., Taub D. D., Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues Experimental Cell Research 2007 313 3 450 461
125. Yang H. Y. T., Erds E. G., Second kininase in human blood plasma Nature 1967 215 5108 1402 1403
126. Yang H. Y., Erds E. G., Levin Y., Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme) Journal of Pharmacology and Experimental Therapeutics 1971 177 1 291 300
127. Corvol P., Michaud A., Soubrier F., Williams T. A., Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme Journal of Hypertension, Supplement 1995 13 3 S3 S10
128. Ehlers M. R. W., Riordan J. F., Angiotensin-converting enzyme: new concepts concerning its biological role Biochemistry 1989 28 13 5311 5318
129. Howard T. E., Shai S.-Y., Langford K. G., Martin B. M., Bernstein K. E., Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene Molecular and Cellular Biology 1990 10 8 4294 4302
130. Hu J., Igarashi A., Kamata M., Nakagawa H., Angiotensin-converting enzyme degrades Alzheimer amyloid -peptide (A ); retards A aggregation, deposition, fibril formation; and inhibits cytotoxicity Journal of Biological Chemistry 2001 276 51 47863 47868
131. Zou K., Maeda T., Watanabe A., Liu J., Liu S., Oba R., Satoh Y.-I., Komano H., Michikawa M., A 42-to-A 40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme Journal of Biological Chemistry 2009 284 46 31914 31920
132. Zou K., Yamaguchi H., Akatsu H., Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition Journal of Neuroscience 2007 27 8628 8635
133. Yamada K., Uchida S., Takahashi S., Takayama M., Nagata Y., Suzuki N., Shirakura S., Kanda T., Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease Brain Research 2010 1352 176 186
134. Hemming M. L., Selkoe D. J., Farris W., Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid -protein metabolism in mouse models of Alzheimer disease Neurobiology of Disease 2007 26 1 273 281
135. Mogi M., Horiuchi M., Effects of angiotensin II receptor blockers on dementia Hypertension Research 2009 32 9 738 740
136. Rosenberg G. A., Matrix metalloproteinases and their multiple roles in neurodegenerative diseases The Lancet Neurology 2009 8 2 205 216
137. Yan P., Hu X., Song H., Yin K., Bateman R. J., Cirrito J. R., Xiao Q., Hsu F. F., Turk J. W., Xu J., Hsu C. Y., Holtzman D. M., Lee J.-M., Matrix metalloproteinase-9 degrades amyloid- fibrils in vitro and compact plaques in situ Journal of Biological Chemistry 2006 281 34 24566 24574
138. Yin K.-J., Cirrito J. R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.-F., Turk J., Xu J., Hsu C. Y., Mills J. C., Holtzman D. M., Lee J.-M., Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid- peptide catabolism Journal of Neuroscience 2006 26 43 10939 10948
139. Deb S., Zhang J. W., Gottschall P. E., Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to -amyloid peptide Journal of Neuroscience Research 1999 55 1 44 53
140. Jung S. S., Zhang W., Van Nostrand W. E., Pathogenic A induces the
141. Lee J.-M., Yin K.-J., Hsin I., Chen S., Fryer J. D., Holtzman D. M., Hsu C. Y., Xu J., Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy Annals of Neurology 2003 54 3 379 382
142. Miners J. S., Baig S., Palmer J., Palmer L. E., Kehoe P. G., Love S., Aβ-degrading enzymes in Alzheimer's disease Brain Pathology 2008 18 2 240 252
143. Berger U. V., Luthi-Carter R., Passani L. A., Elkabes S., Black I., Konradi C., Coyle J. T., Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system Journal of Comparative Neurology 1999 415 1 52 64